| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.34 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |